Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients

Phase 3

Conditions: Breast Cancer

Interventions: Device: Breast Lesion Localization Needles (interv)

First Posted Date: 2009-08-06

Last Posted Date: 2009-08-06

Lead Sponsor: Fudan University

Target Recruit Count: 50

Registration Number: NCT00952679

Locations: 🇨🇳
Cancer hospital, Shanghai, Shanghai, China

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Phase 2

Conditions: Lymphoma

Interventions: Drug: L-asp, DXM, IFO, VP-16, DDP

First Posted Date: 2009-07-07

Last Posted Date: 2012-02-20

Lead Sponsor: Fudan University

Target Recruit Count: 76

Registration Number: NCT00933673

Locations: 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Phase 3

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Thalidomide
Drug: TACE

First Posted Date: 2009-06-16

Last Posted Date: 2011-04-19

Lead Sponsor: Fudan University

Target Recruit Count: 200

Registration Number: NCT00921531

Locations: 🇨🇳
Liver Cancer Institute, Shanghai, Shanghai, China

Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: nimotuzumab
Drug: PF regimen (cisplatin and 5-FU)

First Posted Date: 2009-05-29

Last Posted Date: 2012-02-20

Lead Sponsor: Fudan University

Target Recruit Count: 40

Registration Number: NCT00910117

Locations: 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

Phase 3

Conditions: Breast Cancer

Interventions: Drug: anastrozole
Drug: letrozole
Drug: exemestane

First Posted Date: 2009-05-15

Last Posted Date: 2009-05-15

Lead Sponsor: Fudan University

Target Recruit Count: 540

Registration Number: NCT00902954

Locations: 🇨🇳
Jinsong Lu, Shanghai, Shanghai, China

Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy

Phase 3

Completed

Conditions: Hypoxic-Ischemic Encephalopathy

Interventions: Device: Cooling cap (YJW608-04B)

First Posted Date: 2009-04-29

Last Posted Date: 2009-05-28

Lead Sponsor: Fudan University

Target Recruit Count: 256

Registration Number: NCT00890409

Locations: 🇨🇳
Children's Hospital, Fudan University, Shanghai, Shanghai, China

Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer

Phase 4

Conditions: Colorectal Cancer

Interventions: Drug: tac + folfox4
Drug: folfox4

First Posted Date: 2009-04-02

Last Posted Date: 2009-04-02

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT00874406

Locations: 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles

Phase 4

Completed

Conditions: Colorectal Cancer

Interventions: Drug: 12 cycles of oxaliplatine based adjuvant chemotherapy
Drug: 8 cycles of oxaliplatine based adjuvant chemotherapy

First Posted Date: 2009-03-25

Last Posted Date: 2009-03-25

Lead Sponsor: Fudan University

Target Recruit Count: 400

Registration Number: NCT00868816

Locations: 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer

Phase 4

Completed

Conditions: Unresectable Liver Metastasis of Colorectal Cancer

Interventions: Procedure: Folfox4
Procedure: tac + folfox4

First Posted Date: 2009-03-25

Last Posted Date: 2009-03-25

Lead Sponsor: Fudan University

Target Recruit Count: 200

Registration Number: NCT00869271

Locations: 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

Phase 4

Conditions: Liver Metastasis
Colorectal Cancer

Interventions: Procedure: TACE + folfox 4
Procedure: TAC + folfox4

First Posted Date: 2009-03-25

Last Posted Date: 2009-03-25

Lead Sponsor: Fudan University

Target Recruit Count: 200

Registration Number: NCT00868569

Locations: 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy